Show simple item record

dc.contributor.authorArostegui Madariaga, Inmaculada ORCID
dc.contributor.authorGonzález, Nerea
dc.contributor.authorFernández de Larrea, Nerea
dc.contributor.authorLázaro Aramburu, Santiago
dc.contributor.authorBaré Mañas, Marisa
dc.contributor.authorRedondo, Maximino
dc.contributor.authorSarasqueta, Cristina
dc.contributor.authorGarcia-Gutierrez, Susana
dc.contributor.authorQuintana López, José María
dc.date.accessioned2018-06-29T09:00:12Z
dc.date.available2018-06-29T09:00:12Z
dc.date.issued2018
dc.identifier.citationClinical Epidemiology 10 : 235-251 (2018)es_ES
dc.identifier.issn1179-1349
dc.identifier.urihttp://hdl.handle.net/10810/27788
dc.description.abstractIntroduction: Colorectal cancer is one of the most frequently diagnosed malignancies and a common cause of cancer-related mortality. The aim of this study was to develop and validate a clinical predictive model for 1-year mortality among patients with colon cancer who survive for at least 30 days after surgery. Methods: Patients diagnosed with colon cancer who had surgery for the first time and who survived 30 days after the surgery were selected prospectively. The outcome was mortality within 1 year. Random forest, genetic algorithms and classification and regression trees were combined in order to identify the variables and partition points that optimally classify patients by risk of mortality. The resulting decision tree was categorized into four risk categories. Split-sample and bootstrap validation were performed. ClinicalTrials.gov Identifier: NCT02488161. Results: A total of 1945 patients were enrolled in the study. The variables identified as the main predictors of 1-year mortality were presence of residual tumor, American Society of Anesthesiologists Physical Status Classification System risk score, pathologic tumor staging, Charlson Comorbidity Index, intraoperative complications, adjuvant chemotherapy and recurrence of tumor. The model was internally validated; area under the receiver operating characteristic curve (AUC) was 0.896 in the derivation sample and 0.835 in the validation sample. Risk categorization leads to AUC values of 0.875 and 0.832 in the derivation and validation samples, respectively. Optimal cut-off point of estimated risk had a sensitivity of 0.889 and a specificity of 0.758. Conclusion: The decision tree was a simple, interpretable, valid and accurate prediction rule of 1-year mortality among colon cancer patients who survived for at least 30 days after surgery.es_ES
dc.description.sponsorshipWe are grateful for the support of the 22 participating hospitals, as well as the clinicians and staff members of the various services, research, quality units and medical records sections of these hospitals. We also gratefully acknowledge the patients who participated in the study. We would like to thank Editage (www.editage.com) for English language editing. We also wish to thank the anonymous referees for providing comments, which led to substantial improvement of the article. Financial support for this study was provided, in part, by grants from the Instituto de Salud Carlos III (PS09/00314, PS09/00910, PS09/00746, PS09/00805, PI09/90460, PI09/90490, PI09/90453, PI09/90441, PI09/90397 and the thematic network REDISSEC - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas), co-funded by European Regional Development Fund/European Social Fund (ERDF/ESF "Investing in your future"); the Research Committee of the Hospital Galdakao; the Department of Health and the Department of Education, Language Policy and Culture from the Basque Government (2010111098, IT620-13 and BERC 2014-2017 program); the Spanish Ministry of Economy and Competitiveness MINECO and FEDER (MTM2013-40941-P, MTM2016-74931-P and BCAM Severo Ochoa excellence accreditation SEV-2013-0323). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing and publishing the report.es_ES
dc.language.isoenges_ES
dc.publisherDove Medical Presses_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/MTM2013-40941-Pes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/MTM2016-74931-Pes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/SEV-2013-0323es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectclinical prediction ruleses_ES
dc.subjectcolonic neoplasmses_ES
dc.subjectcolorectal surgeryes_ES
dc.subjecttree-based methodses_ES
dc.subjectprediction modeles_ES
dc.subject1-year-mortalityes_ES
dc.subjectcolorectal-canceres_ES
dc.subjectcurative resectiones_ES
dc.subjectmicroarray dataes_ES
dc.subjectdecision treees_ES
dc.subjectmodeles_ES
dc.subjectmorbidityes_ES
dc.subjectsurgeryes_ES
dc.subjectregressiones_ES
dc.subjectprognosises_ES
dc.subjectstratificationes_ES
dc.titleCombining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon canceres_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2018 Arostegui et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://www.dovepress.com/combining-statistical-techniques-to-predict-postsurgical-risk-of-1-yea-peer-reviewed-fulltext-article-CLEPes_ES
dc.identifier.doi10.2147/CLEP.S146729
dc.departamentoesMatemática aplicadaes_ES
dc.departamentoeuMatematika aplikatuaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2018 Arostegui et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Except where otherwise noted, this item's license is described as © 2018 Arostegui et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).